Literature DB >> 1692558

Human gamma- to beta-globin gene switching in transgenic mice.

R R Behringer1, T M Ryan, R D Palmiter, R L Brinster, T M Townes.   

Abstract

Previous studies demonstrated correct tissue- and temporal-specific expression of human gamma- and beta-globin genes in transgenic mice; however, expression was extremely low. When the erythroid-specific DNase I super-hypersensitive (HS) sites that are normally located upstream of the human beta-globin locus were fused individually to gamma- or beta-globin genes, expression increased to endogenous mouse globin levels but temporal specificity was lost. In contrast, when the HS sequences were combined with fragments containing both gamma- and beta-globin genes, correct developmental regulation was restored. We suggest that human gamma- to beta-globin gene switching during development results from competition of individual globin gene family members for interaction with the HS sequences and that factors influencing these competitive interactions determine temporal specificity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692558     DOI: 10.1101/gad.4.3.380

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  112 in total

1.  The role of the -50 region of the human gamma-globin gene in switching.

Authors:  M S Ristaldi; D Drabek; J Gribnau; D Poddie; N Yannoutsous; A Cao; F Grosveld; A M Imam
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

2.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.

Authors:  P A Ney; B P Sorrentino; C H Lowrey; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

3.  Beta-globin locus activation regions: conservation of organization, structure, and function.

Authors:  Q L Li; B Zhou; P Powers; T Enver; G Stamatoyannopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Correction of sickle cell disease by homologous recombination in embryonic stem cells.

Authors:  Li-Chen Wu; Chiao-Wang Sun; Thomas M Ryan; Kevin M Pawlik; Jinxiang Ren; Tim M Townes
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

Review 5.  Future prospects for treatment of hemoglobinopathies.

Authors:  J A Stamatoyannopoulos
Journal:  West J Med       Date:  1992-12

6.  Selective expression of human X chromosome-linked green opsin genes.

Authors:  J Winderickx; L Battisti; A G Motulsky; S S Deeb
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements.

Authors:  M Walters; D I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Beta-thalassaemia: molecular pathogenesis and clinical variability.

Authors:  A E Kulozik
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

9.  Regulated expression of the human beta globin gene in transgenic mice requires an upstream globin or nonglobin promoter.

Authors:  K P Anderson; J A Lloyd; E Ponce; S C Crable; J C Neumann; J B Lingrel
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

10.  Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression.

Authors:  J J Caterina; D Donze; C W Sun; D J Ciavatta; T M Townes
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.